U.S. Banks Stock News

NYSE:SOLV
NYSE:SOLVMedical Equipment

Solventum Expands MedSurg With Acera Deal As Valuation Signals Upside

Solventum (NYSE:SOLV) has completed its acquisition of Acera Surgical, a bioscience company focused on regenerative wound care. The deal expands Solventum's MedSurg portfolio and adds exposure to regenerative medicine applications in US acute care settings. The company expects the transaction to have a long term accretive impact. For you as an investor, this move puts more attention on Solventum's MedSurg business, which already plays a central role in hospital and surgical settings...
NYSE:BBY
NYSE:BBYSpecialty Retail

Should Best Buy’s Raised EPS Guidance and Stronger Tech Sales Require Action From Best Buy (BBY) Investors?

In November 2025, Best Buy reported past-third-quarter results that topped analyst expectations, with comparable sales and total revenue both increasing and management lifting its fiscal 2026 adjusted EPS guidance to a US$6.25–US$6.35 range. The stronger performance in computing, gaming, and mobile phones highlighted the importance of these categories to Best Buy’s earnings power and future guidance. Now we’ll explore how Best Buy’s upgraded earnings outlook potentially reshapes the earlier...
NYSE:VRT
NYSE:VRTElectrical

Vertiv Holdings Co (VRT) Margin Expansion Reinforces Bullish Narratives In Q3 FY 2025

Vertiv Holdings Co (VRT) has put up another busy quarter, with Q3 FY 2025 revenue at US$2.7 billion and basic EPS of US$1.04 setting the tone for its latest financial update. The company has seen revenue progress from US$2.1 billion and EPS of US$0.47 in Q3 FY 2024 to US$2.7 billion and EPS of US$1.04 in Q3 FY 2025. Trailing 12 month net income of US$1.0 billion on revenue of US$9.7 billion points to a business where margins are front and center for investors watching this earnings print. See...
NYSE:IVZ
NYSE:IVZCapital Markets

Is It Time To Reassess Invesco (IVZ) After A 51% One Year Share Price Gain?

If you are trying to figure out whether Invesco's current share price really stacks up, you are in the right place for a closer look at what sits behind the ticker. Invesco's stock has seen a 51.0% return over the past year, even though the last month brought an 8.1% decline from a recent close of US$26.44 and a 1.5% dip over the last week. Recent headlines around Invesco have focused on its position as a global asset manager and how investors are reacting to shifts in sentiment toward the...
NYSE:POR
NYSE:PORElectric Utilities

Portland General’s Distribution Plan Settlement Could Be A Game Changer For Portland General Electric (POR)

Portland General Electric recently reached a settlement agreement on its Distribution System Plan Alternative Recovery Mechanism and submitted it to the Oregon Public Utility Commission, prompting differing analyst reactions to the regulatory shift. The split between Ladenburg Thalmann’s downgrade and BTIG’s reaffirmed optimism highlights how sensitive Portland General Electric’s outlook is to regulatory clarity and cost recovery mechanisms. We’ll now examine how this Distribution System...
NYSE:DXC
NYSE:DXCIT

A Look At DXC Technology (DXC) Valuation After New AI Workspace Rollout And Business Unit Launch

DXC Technology (DXC) has just finished rolling out Amazon Quick, an AI powered digital workspace, across its 115,000 person workforce and created a new unit to help clients scale similar AI deployments. See our latest analysis for DXC Technology. Despite the AI push and recent earnings update, DXC Technology's recent share price momentum has been weak. The 1 month share price return shows an 8.90% decline and the 1 year total shareholder return shows a 31.11% decline, while the 3 month share...
NasdaqGS:NWE
NasdaqGS:NWEIntegrated Utilities

How Investors Are Reacting To NorthWestern Energy (NWE) Revenue Growth, Margin Squeeze And A Higher Dividend

NorthWestern Energy Group, Inc. has reported its full-year 2025 results, with revenue rising to US$1,610.6 million while net income declined to US$181.1 million, and at the same time the board approved a higher quarterly dividend of US$0.67 per share payable on March 31, 2026. The combination of stronger top-line performance, weaker earnings and a 1.5% dividend increase highlights management’s focus on returning cash to shareholders while operating through profit margin pressure. Next, we’ll...
NYSEAM:ESP
NYSEAM:ESPElectrical

Espey Mfg. & Electronics (ESP) Net Margin Strength Challenges Slower Growth Narratives

Q2 2026 earnings snapshot and what it means for the Espey story Espey Mfg. & Electronics (ESP) has just posted its Q2 2026 numbers, with the latest reported quarter showing revenue of about US$9.1 million and basic EPS of US$0.80, supported by trailing twelve month EPS of US$3.30 on revenue of US$42.6 million. Over the past reported periods, the company has seen quarterly revenue move between US$9.1 million and US$13.6 million while basic EPS has ranged from US$0.63 to US$1.10. This gives...
NasdaqGS:CZR
NasdaqGS:CZRHospitality

Is Caesars Entertainment (CZR) Pricing In Too Much Pessimism After Its 1 Year Share Price Slump

If you are wondering whether Caesars Entertainment's share price now reflects a bargain or a value trap, it helps to step back and look at what the current market is really pricing in. The stock last closed at US$19.84, with returns of a 2.3% decline over 7 days, a 20.2% decline over 30 days, a 15.8% decline year to date and a 49.0% decline over 1 year, which may have some investors reassessing both the upside potential and the risks. These moves come as Caesars Entertainment continues to...
NasdaqCM:VRRM
NasdaqCM:VRRMProfessional Services

Verra Mobility’s NYC Camera Deal And What It May Mean For Valuation

Verra Mobility secured a new five year contract with the New York City Department of Transportation to expand and manage automated enforcement camera programs. The agreement broadens red light and bus lane safety coverage across all five boroughs and adds technology upgrades and community focused commitments. The contract extends a long running relationship between Verra Mobility and NYC DOT and is tied to legislatively supported program growth. For investors watching Verra Mobility,...
NYSE:NEXA
NYSE:NEXAMetals and Mining

Is It Time To Reassess Nexa Resources (NEXA) After Its 123% One-Year Surge?

If you are wondering whether Nexa Resources at around US$12.38 is still attractively priced after a strong run, you are not alone. This article is built to help you frame that value question clearly. The stock has had a mixed short term patch with a 3.1% decline over the last 7 days, but it also shows returns of 15.3% over 30 days, 40.8% year to date, 122.9% over 1 year and 95.9% over 3 years, as well as 43.4% over 5 years. Recent moves are taking place against a backdrop of continuing...
NYSE:AMP
NYSE:AMPCapital Markets

Ameriprise Legal Dispute Raises Questions For Advisor Relations And Valuation

Ameriprise Financial (NYSE:AMP) is in a legal dispute with LPL Financial involving advisor transitions and data access. A federal appeals court has allowed a group of advisors to intervene in the case and pause searches of their personal devices. The ruling is tied to ongoing FINRA arbitration, which is shaping how evidence and advisor rights are handled. Ameriprise Financial, trading at about $485.96, enters this dispute with a mixed return profile, including a 44.7% gain over 3 years and...
NYSE:CCL
NYSE:CCLHospitality

A Look At Carnival Corporation (CCL) Valuation After Earnings Surprises And New Fleet Agreements

Carnival Corporation & (CCL) earnings surprises and operations in focus Carnival Corporation & (CCL) is back on investor radars after four straight quarters of positive earnings surprises, alongside fresh fleet wide operational agreements and new port development projects that spotlight ongoing business adjustments. See our latest analysis for Carnival Corporation &. Despite a small 1 day share price pullback, Carnival’s 90 day share price return of 26.59% and 1 year total shareholder return...
NasdaqGS:EXLS
NasdaqGS:EXLSProfessional Services

EXL Patents New AI Data Tools As Shares Trade Below Targets

ExlService Holdings (NasdaqGS:EXLS) has received 10 new U.S. patents covering AI and data-focused solutions. The patents span multiple sectors, including insurance, healthcare, retail, utilities, and financial services. Newly protected capabilities target data readiness for AI, workflow automation, and tuning large language models for enterprise use. For shareholders watching NasdaqGS:EXLS, this patent batch lands after a challenging stretch for the stock, with the share price at $30.25 and...
NasdaqGS:GEN
NasdaqGS:GENSoftware

Gen Digital (GEN) Is Up 7.6% After Q3 Beat And AI Agent Trust Hub Launch - What's Changed

Gen Digital Inc. recently reported third-quarter fiscal 2026 results, with sales rising to US$1,240 million and net income to US$192 million year on year, while also declaring a quarterly dividend of US$0.125 per share payable on March 11, 2026. Alongside these results, the company launched its Gen Agent Trust Hub to address emerging security risks from autonomous AI agents, signaling an effort to position its cyber safety platform at the center of the AI “agentic” ecosystem. We’ll now...
NYSE:CNS
NYSE:CNSCapital Markets

Cohen And Steers ETF Shift Tests Valuation Premium And Dividend Support

Cohen & Steers plans to convert its Future of Energy Fund into an ETF. The shift aligns the firm with a broader move by traditional asset managers toward ETF structures. The conversion responds to changing investor preferences around access, fees, and trading flexibility. Cohen & Steers, listed as NYSE:CNS, is moving its Future of Energy Fund into an ETF format at a time when investors are paying close attention to listed asset managers and their product line ups. The shares most recently...
NasdaqGS:VRSN
NasdaqGS:VRSNIT

Does VeriSign (VRSN) Leaning on Dividends and Buybacks Reframe Its Core Growth Narrative?

VeriSign, Inc. recently reported its fourth-quarter and full-year 2025 results, showing higher sales and net income year over year, while also announcing a quarterly dividend increase to US$0.81 per share and updating investors on progress under its long-running share repurchase program. Beyond the headline growth in revenue and earnings, the combination of a higher dividend and continued buybacks highlights management’s emphasis on returning cash to shareholders alongside its core internet...
NasdaqGS:NBIX
NasdaqGS:NBIXBiotechs

Is Neurocrine Biosciences (NBIX) Pricing Reflecting Its Strong 1 Year Share Performance?

If you are wondering whether Neurocrine Biosciences is fairly priced or offering value right now, you are not alone. This article is designed to help you frame that question clearly. The stock last closed at US$137.44, with returns of 3.6% over 30 days and 17.3% over 1 year. These figures can change how investors think about both its potential upside and its risk. Recent news coverage has focused on Neurocrine Biosciences as a key player in the US pharmaceuticals and biotech space, with...
NasdaqGS:TEAM
NasdaqGS:TEAMSoftware

Is It Time To Reassess Atlassian (TEAM) After A 73% Share Price Slide

If you are wondering whether Atlassian shares are starting to look interesting at today’s price, this article will walk through what the current market value actually reflects and what it might be missing. Atlassian’s share price closed at US$86.97, with returns of a 17.2% decline over 7 days, 40.6% decline over 30 days, 43.8% decline year to date and 72.7% decline over the past year. Even the 3 year and 5 year returns of 53.6% decline and 65.3% decline respectively show how much sentiment...
NasdaqGS:SNDX
NasdaqGS:SNDXBiotechs

Is It Time To Reassess Syndax Pharmaceuticals (SNDX) After A 46% One Year Share Price Gain?

If you are wondering whether Syndax Pharmaceuticals at US$21.71 is offering good value today, you are not alone. This article is here to unpack that question calmly and clearly. The stock has returned 6.3% over the last 7 days, 4.8% over 30 days, 1.9% year to date and 46.1% over the past year. However, the 3 year and 5 year returns of negative 16.5% and negative 5.0% show a more mixed longer term picture. These moves have arrived alongside ongoing interest in Syndax Pharmaceuticals' pipeline...
NYSE:AVTR
NYSE:AVTRLife Sciences

Avantor (AVTR) Q3 Loss Of US$711.8 Million Tests Bullish Earnings Narratives

How Avantor's FY 2025 Numbers Set the Stage for the Next Chapter Avantor (AVTR) just posted its FY 2025 third quarter results with revenue of US$1,623.8 million, a basic EPS loss of US$1.04 and net income loss of US$711.8 million, putting a sharp spotlight on profitability. The company has seen quarterly revenue move from US$1,714.4 million in Q3 2024 to US$1,686.6 million in Q4 2024, then to US$1,581.4 million and US$1,683.4 million in Q1 and Q2 2025, with EPS shifting from US$0.08 to...
NasdaqGS:CASH
NasdaqGS:CASHBanks

Is It Time To Reassess Pathward Financial (CASH) After Recent Share Price Strength?

If you are wondering whether Pathward Financial's current share price still offers value, it helps to first see how its market price lines up with what the business might be worth. The stock last closed at US$89.59, with returns of 21.8% over the past month, 24.7% year to date and 14.0% over the last year, which can change how investors think about both upside and risk. Recent news coverage has focused on Pathward Financial's position in the U.S. banking sector and how its business model...
NYSE:NU
NYSE:NUBanks

Is It Too Late To Consider Nu Holdings (NU) After A 232% Three Year Surge?

If you are wondering whether Nu Holdings is still good value after its strong run, you are not alone. The stock has quickly become a talking point for many growth focused investors. The share price recently closed at US$17.41, with total returns of 2.3% over the past week, 2.2% over the past month, 2.3% year to date and 27.6% over the last year, while the 3 year return sits at 232.3%. This naturally raises questions about what is already priced in. Recent news flow has centered on Nu...
OTCPK:FNMA
OTCPK:FNMADiversified Financial

Fannie Mae (OTCPK:FNMA) Q3 Net Income Rebound Challenges Persistent Loss Narrative

Federal National Mortgage Association (FNMA) has just posted its FY 2025 third quarter numbers, with revenue of US$7.0b and EPS of US$0.66 setting the tone for the latest update. Over recent quarters, revenue has moved from US$8.0b in FY 2024 Q2 to US$7.4b in Q3 and US$7.8b in Q4, then to US$7.2b in FY 2025 Q1, US$6.5b in Q2 and US$7.0b in Q3. EPS has ranged from US$1.50 in FY 2024 Q2 and US$0.69 in Q3 to close to zero in late 2024 and early 2025, before landing at US$1.19 in FY 2025 Q2 and...